Cargando…

Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus

Several countries in the European Union (EU) and European Economic Area (EEA) established and/or scaled up HIV pre-exposure prophylaxis (PrEP) programmes between 2016 and 2023. Data on PrEP programmes’ performance and effectiveness in reaching those most in need will be needed to assess regional pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanhamel, Jef, Wijstma, Eline, Deblonde, Jessika, Laga, Marie, Vuylsteke, Bea, Nöstlinger, Christiana, Noori, Teymur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318945/
https://www.ncbi.nlm.nih.gov/pubmed/37289428
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.23.2200546
_version_ 1785068145821614080
author Vanhamel, Jef
Wijstma, Eline
Deblonde, Jessika
Laga, Marie
Vuylsteke, Bea
Nöstlinger, Christiana
Noori, Teymur
author_facet Vanhamel, Jef
Wijstma, Eline
Deblonde, Jessika
Laga, Marie
Vuylsteke, Bea
Nöstlinger, Christiana
Noori, Teymur
author_sort Vanhamel, Jef
collection PubMed
description Several countries in the European Union (EU) and European Economic Area (EEA) established and/or scaled up HIV pre-exposure prophylaxis (PrEP) programmes between 2016 and 2023. Data on PrEP programmes’ performance and effectiveness in reaching those most in need will be needed to assess regional progress in the roll-out of PrEP. However, there is a lack of commonly defined indicators for routine monitoring to allow for minimum comparability. We propose a harmonised PrEP monitoring approach for the EU/EEA, based on a systematic and evidence-informed consensus-building process involving a broad and multidisciplinary expert panel. We present a set of indicators, structured along relevant steps of an adapted PrEP care continuum, and offer a prioritisation based on the degree of consensus among the expert panel. We distinguish between ‘core’ indicators deemed essential for any PrEP programme in the EU/EEA, vs ‘supplementary’ and ‘optional’ indicators that provide meaningful data, yet where experts evaluated their feasibility for data collection and reporting as very context-dependent. By combining a standardised approach with strategic opportunities for adaptation and complementary research, this monitoring framework will contribute to assess the impact of PrEP on the HIV epidemic in Europe.
format Online
Article
Text
id pubmed-10318945
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-103189452023-07-05 Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus Vanhamel, Jef Wijstma, Eline Deblonde, Jessika Laga, Marie Vuylsteke, Bea Nöstlinger, Christiana Noori, Teymur Euro Surveill Perspective Several countries in the European Union (EU) and European Economic Area (EEA) established and/or scaled up HIV pre-exposure prophylaxis (PrEP) programmes between 2016 and 2023. Data on PrEP programmes’ performance and effectiveness in reaching those most in need will be needed to assess regional progress in the roll-out of PrEP. However, there is a lack of commonly defined indicators for routine monitoring to allow for minimum comparability. We propose a harmonised PrEP monitoring approach for the EU/EEA, based on a systematic and evidence-informed consensus-building process involving a broad and multidisciplinary expert panel. We present a set of indicators, structured along relevant steps of an adapted PrEP care continuum, and offer a prioritisation based on the degree of consensus among the expert panel. We distinguish between ‘core’ indicators deemed essential for any PrEP programme in the EU/EEA, vs ‘supplementary’ and ‘optional’ indicators that provide meaningful data, yet where experts evaluated their feasibility for data collection and reporting as very context-dependent. By combining a standardised approach with strategic opportunities for adaptation and complementary research, this monitoring framework will contribute to assess the impact of PrEP on the HIV epidemic in Europe. European Centre for Disease Prevention and Control (ECDC) 2023-06-08 /pmc/articles/PMC10318945/ /pubmed/37289428 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.23.2200546 Text en This article is copyright of the authors or their affiliated institutions, 2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Perspective
Vanhamel, Jef
Wijstma, Eline
Deblonde, Jessika
Laga, Marie
Vuylsteke, Bea
Nöstlinger, Christiana
Noori, Teymur
Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus
title Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus
title_full Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus
title_fullStr Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus
title_full_unstemmed Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus
title_short Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus
title_sort developing evidence-informed indicators to monitor hiv pre-exposure prophylaxis programmes across eu/eea countries: a multi-stakeholder consensus
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318945/
https://www.ncbi.nlm.nih.gov/pubmed/37289428
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.23.2200546
work_keys_str_mv AT vanhameljef developingevidenceinformedindicatorstomonitorhivpreexposureprophylaxisprogrammesacrosseueeacountriesamultistakeholderconsensus
AT wijstmaeline developingevidenceinformedindicatorstomonitorhivpreexposureprophylaxisprogrammesacrosseueeacountriesamultistakeholderconsensus
AT deblondejessika developingevidenceinformedindicatorstomonitorhivpreexposureprophylaxisprogrammesacrosseueeacountriesamultistakeholderconsensus
AT lagamarie developingevidenceinformedindicatorstomonitorhivpreexposureprophylaxisprogrammesacrosseueeacountriesamultistakeholderconsensus
AT vuylstekebea developingevidenceinformedindicatorstomonitorhivpreexposureprophylaxisprogrammesacrosseueeacountriesamultistakeholderconsensus
AT nostlingerchristiana developingevidenceinformedindicatorstomonitorhivpreexposureprophylaxisprogrammesacrosseueeacountriesamultistakeholderconsensus
AT nooriteymur developingevidenceinformedindicatorstomonitorhivpreexposureprophylaxisprogrammesacrosseueeacountriesamultistakeholderconsensus